In accordance with its ubiquitous expression, MECP2 has also been linked to non‐neurological diseases, such as lupus erythematosus, rheumatoid arthritis and cancer (Ezeonwuka & Rastegar, 2014). Here, MECP2 is linked to nervous system disorder.